Skip to main content
. 2011 Oct 5;11:426. doi: 10.1186/1471-2407-11-426

Table 5.

Univariate and multivariate predictors of overall survival

Univariate model Multivariable model (stepwise)
Variables Median OS (days) 95% CI p-value (Log-rank) Hazard ratio 95% CI p-value

Gender Female 365 276-501 0.05

Male 270 204-346

Age < 65 years 325 271-400 0.81

≥ 65 years 297 210-398

Albumin ≥ 35 g/L 325 271-365 0.02

< 35 g/L 54 42-408

LDH Normal 366 320-501 0.001

Elevated 210 147-276 1.75 1.24-2.46 0.001

No. of metastatic sites ≤ 2 358 299-446 0.0001

> 2 210 136-290 1.68 1.18-2.40 0.004

ECOG Performance Status 0 366 302-464 0.02

> 0 270 158-325 1.42 1.00-1.99 0.05

Hemoglobin ≥ 12 g/dL 350 273-412 0.09

< 12 g/dL 276 185-346

WBC ≤ 10.5 × 109/L 345 276-398 0.07

> 10.5 × 109/L 236 103-352

Platelets ≤ 400 × 109/L 329 273-398 0.23

> 400 × 109/L 261 137-352

Lymphocytes ≥ 0.7 × 109/L 346 290-400 0.04

< 0.7 × 109/L 166 99-315

Lung metastases No 338 271-414 0.58

Yes 302 223-365

Liver metastases No 366 297-501 0.01

Yes 250 191-329

Bone metastases No 329 276-365 0.32

Yes 261 135-433

Brain No 320 270-358 0.47

Yes 269.5 40-499

Peritoneal Mets No 325 250-365 0.99

Yes 315 257-474

No. of prior treatments < 3 302 266-365 0.76

≥ 3 320 227-400

Abbreviations: LDH = lactate dehydrogenase; No. = number; ECOG = Eastern Cooperative Oncology Group; WBC = white blood cells; OS = overall survival; CI = confidence interval